Inmedix focuses on advancing the field of diagnostics through innovative technologies, particularly in the realm of medical-grade heart rate variability (HRV). Their research emphasizes the importance of precision and regulatory oversight in diagnostics, which is crucial for effective patient care. The company is actively involved in exploring the science behind immuno-autonomics, a field that examines the interplay between the nervous and immune systems, particularly in relation to autoimmune diseases like rheumatoid arthritis. Inmedix aims to leverage this understanding to develop diagnostic tools that can provide valuable insights into patient health and treatment responses.

The company is also committed to community engagement, as evidenced by its annual charity golf tournament that supports children with arthritis. Inmedix has successfully raised significant funds for this cause, demonstrating its dedication to both medical innovation and social responsibility. Additionally, the company is in the process of commercializing its HRV technology, which has garnered attention from investors and regulatory bodies alike. By combining cutting-edge research with a focus on patient advocacy, Inmedix is positioned to make a meaningful impact in the healthcare landscape.

United States

Inmedixfocuses on autonomic nervous system (ANS) control of stress responses within the brain. In the setting of an autoimmune disease, ANS stress can significantly intensify an autoimmune disease. Inmedixcall’sit Immuno-autonomics. Theyseek to understand and block this process to allow current autoimmune disease therapies to work much better.

Inmedix

Company Details